Lighter monitoring after stroke clot-busting treatment
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests whether less intensive monitoring after clot-busting treatment for stroke is safe and effective. It aims to make recovery more comfortable by reducing constant checks while still ensuring safety.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You had a stroke caused by a blocked blood vessel (ischemic stroke).
- You received a clot-busting medicine like alteplase or tenecteplase as part of your care.
- Your vital signs are stable, with blood pressure no higher than 180/105.
- Two hours after the medicine, your stroke symptoms are mild to moderate, with a score under 10 on the NIHSS scale.
- You do not need intensive care or close monitoring, and you can be cared for on a general ward.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether keeping blood pressure very tightly controlled after a stroke clot removal (thrombectomy) is better than standard care. It may help people who have had an acute stroke from a large brain artery blockage and still have high blood pressure after the procedure.
This trial looks at how blood flow and brain activity change in the first days after a stroke caused by a large blockage in the front part of the brain. It tests if certain patterns can help predict recovery after a procedure to remove the clot.
This trial tests how managing high blood pressure during clot-dissolving treatment for acute ischemic stroke affects recovery. It is for patients who have high blood pressure at the start of treatment.
This trial tests a strategy for managing high blood pressure in people having an acute ischemic stroke who are about to receive clot-busting medication. It aims to see if carefully lowering blood pressure within a specific range improves outcomes.
This trial tests whether giving a clot-busting drug remotely (via video link with a specialist) can help people having an acute stroke. It aims to see if this approach can improve recovery and outcomes for stroke patients in Oman.
This trial compares different ways to restore blood flow in people who have had a mild ischemic stroke. Doctors want to see which treatment approach is safest and most effective for improving recovery, using clot-busting medicine and/or a clot-removal procedure.
Hear when a new Stroke, Ischemic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.